These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26974368)

  • 21. Effect of drug-eluting stents on frequency of repeat revascularization in patients with unstable angina pectoris or non-ST-elevation myocardial infarction.
    Li Y; Torguson R; Syed AI; Ben-Dor I; Collins SD; Maluenda G; Scheinowitz M; Kaneshige K; Xue Z; Lemesle G; Satler LF; Suddath WO; Kent KM; Lindsay J; Pichard AD; Waksman R
    Am J Cardiol; 2009 Dec; 104(12):1654-9. PubMed ID: 19962470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Why surgery won the SYNTAX trial and why it matters.
    Mack M; Baumgarten H; Lytle B
    J Thorac Cardiovasc Surg; 2016 Nov; 152(5):1237-1240. PubMed ID: 27283748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early results of off-pump coronary artery bypass graft surgery using bilateral internal thoracic artery grafts in octogenarian patients during ten years.
    El Diasty M; Gonzalez JA; Perez J; Cid F; Mosquera V; Cuenca J; Juffe A
    Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):104-7. PubMed ID: 18948307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence, predictors, and implications of reinfarction after primary percutaneous coronary intervention in ST-segment-elevation myocardial infarction: the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction Trial.
    Stone SG; Serrao GW; Mehran R; Tomey MI; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Möckel M; Brener SJ; Dangas G; Stone GW
    Circ Cardiovasc Interv; 2014 Aug; 7(4):543-51. PubMed ID: 24939928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Culprit vessel versus multivessel intervention at the time of primary percutaneous coronary intervention in patients with ST-segment-elevation myocardial infarction and multivessel disease: real-world analysis of 3984 patients in London.
    Iqbal MB; Ilsley C; Kabir T; Smith R; Lane R; Mason M; Clifford P; Crake T; Firoozi S; Kalra S; Knight C; Lim P; Malik IS; Mathur A; Meier P; Rakhit RD; Redwood S; Whitbread M; Bromage D; Rathod K; MacCarthy P; Dalby M;
    Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):936-43. PubMed ID: 25371542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coronary artery bypass surgery with on-pump beating-heart technique.
    Fouda M
    Asian Cardiovasc Thorac Ann; 2007 Oct; 15(5):392-5. PubMed ID: 17911066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of inhospital mortality, length of hospitalization, costs, and vascular complications of percutaneous coronary interventions guided by ultrasound versus angiography.
    Singh V; Badheka AO; Arora S; Panaich SS; Patel NJ; Patel N; Pant S; Thakkar B; Chothani A; Deshmukh A; Manvar S; Lahewala S; Patel J; Patel S; Jhamnani S; Bhinder J; Patel P; Savani GT; Patel A; Mohamad T; Gidwani UK; Brown M; Forrest JK; Cleman M; Schreiber T; Grines C
    Am J Cardiol; 2015 May; 115(10):1357-66. PubMed ID: 25824542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction and Concurrent Active Gastrointestinal Bleeding.
    Mohar DS; Seto AH; Kern MJ
    Circ Cardiovasc Interv; 2015 Oct; 8(10):. PubMed ID: 26450353
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of Baseline Characteristics and Inhospital Outcomes of Patients and Use of Bare Metal Versus Drug-Eluting Stents During Percutaneous Coronary Intervention 2005 to 2015 at a Single Tertiary Hospital.
    Didier R; Gaglia MA; Lipinski MJ; Koifman E; Kiramijyan S; Negi S; Gai J; Torguson R; Pichard AD; Waksman R
    Am J Cardiol; 2017 May; 119(9):1324-1330. PubMed ID: 28258727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Percutaneous coronary intervention in eastern urban China: 2001-2011].
    Zheng X; Bai XK; Huo XQ; Wang B; Wang SM; Li J; Li X; Jiang LX
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(23):1863-70. PubMed ID: 27356801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stent thrombosis with second-generation drug-eluting stents compared with bare-metal stents: network meta-analysis of primary percutaneous coronary intervention trials in ST-segment–elevation myocardial infarction [corrected].
    Philip F; Agarwal S; Bunte MC; Goel SS; Tuzcu EM; Ellis S; Kapadia SR
    Circ Cardiovasc Interv; 2014 Feb; 7(1):49-61. PubMed ID: 24280964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 3D optical coherence tomography: new insights into the process of optimal rewiring of side branches during bifurcational stenting.
    Okamura T; Onuma Y; Yamada J; Iqbal J; Tateishi H; Nao T; Oda T; Maeda T; Nakamura T; Miura T; Yano M; Serruys PW
    EuroIntervention; 2014 Dec; 10(8):907-15. PubMed ID: 24531393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of candesartan on cardiovascular events after drug-eluting stent implantation in patients with coronary artery disease: The 4C trial.
    Sakamoto T; Ogawa H; Nakao K; Hokimoto S; Tsujita K; Koide S; Yamamoto N; Shimomura H; Matsumura T; Oshima S; Kikuta K; Oka H; Kimura K; Matsui K;
    J Cardiol; 2016 Apr; 67(4):371-7. PubMed ID: 26254019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. One-year outcomes in 1,010 unselected patients treated with the PROMUS Element everolimus-eluting stent: the multicentre PROMUS Element European Post-Approval Surveillance Study.
    Thomas MR; Birkemeyer R; Schwimmbeck P; Legrand V; Moreno R; Briguori C; Werner N; Bramucci E; Ungi I; Richardt G; Underwood PL; Dawkins KD
    EuroIntervention; 2015 Mar; 10(11):1267-71. PubMed ID: 25631367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Everolimus-eluting stents or bypass surgery for multivessel coronary disease.
    Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL
    N Engl J Med; 2015 Mar; 372(13):1213-22. PubMed ID: 25775087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association of red blood cell distribution width with drug-eluting stent restenosis in unstable angina pectoris patients.
    Zhao K; Li Y; Jin Z; Gao S
    Int J Cardiol; 2015 Jul; 191():1-3. PubMed ID: 25965588
    [No Abstract]   [Full Text] [Related]  

  • 38. Outcomes with coronary artery bypass graft surgery versus percutaneous coronary intervention for patients with diabetes mellitus: can newer generation drug-eluting stents bridge the gap?
    Bangalore S; Toklu B; Feit F
    Circ Cardiovasc Interv; 2014 Aug; 7(4):518-25. PubMed ID: 24939927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coronary artery bypass graft surgery versus percutaneous coronary intervention with first-generation drug-eluting stents: a meta-analysis of randomized controlled trials.
    Al Ali J; Franck C; Filion KB; Eisenberg MJ
    JACC Cardiovasc Interv; 2014 May; 7(5):497-506. PubMed ID: 24746647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Looking beyond angioplasty: the importance of left ventricular dysfunction.
    Moscicki R; Di Mario C
    Eur Heart J; 2014 Nov; 35(43):2998-3000. PubMed ID: 25168600
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.